PINK:NYE-Simplify Exchange Traded Funds - Simplify Health Care ETF (USD)

ETF | Others |

Last Closing

USD 33.07

Change

0.00 (0.00)%

Market Cap

USD 0.25B

Volume

0.11M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Under normal circumstances, the fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The fund adviser defines health care companies as companies included in the Global Industry Classification Standard health care sector. The fund will typically invest in 50 " 100 health care companies. The adviser generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-21 )

ETFs Containing PINK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.96% 90% A- 82% B
Dividend Return 0.22% 5% F 4% F
Total Return 21.18% 88% B+ 79% B-
Trailing 12 Months  
Capital Gain 30.04% 83% B 78% C+
Dividend Return 0.67% 10% F 7% C-
Total Return 30.71% 81% B- 75% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.35% 71% C- 54% F
Dividend Return 4.70% 68% D+ 47% F
Total Return 0.36% 21% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 9.06% 52% F 80% B-
Risk Adjusted Return 51.90% 68% D+ 69% C-
Market Capitalization 0.25B 74% C 38% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.